-
CRISPR Targeting of VZV ORF62/71: Study Insights
2026-10-07
Wu and colleagues evaluated AAV-delivered CRISPR/Cas9 cleavage of the duplicated VZV ORF62/71 region as a strategy to suppress productive replication and neuronal reactivation. The study provides strong in vitro evidence for sequence-dependent antiviral activity, while also highlighting the substantial delivery, safety, and translational barriers that remain before clinical application.
-
Trilaurin: Why the C12 Boundary Matters
2026-10-06
Trilaurin, also known as Glycerol Tridodecanoate, connects lipid formulation, biocatalysis, oral drug delivery, and immunotoxicology. This article interprets the evidence across these fields while explaining why a negative C12 finding in a mouse hypersensitivity model is scientifically important.
-
Cardiogreen: Translational Phototherapy’s Next Frontier
2026-10-05
Cardiogreen (Indocyanine green) is best understood not simply as a near-infrared dye, but as a translational bridge between vascular diagnostics and light-responsive biology. This article examines the evidence for linking its photophysical profile with immunogenic cell death, macrophage engagement, and the limits of extrapolating photothermal findings to photodynamic therapy.
-
From S-Phase Signal to Translational Insight
2026-10-05
A mechanistic and strategic perspective on using EdU-based DNA synthesis measurements to connect cell-cycle biology with translational studies of pulmonary vascular remodeling, exosome therapeutics, pharmacodynamics, and genotoxicity.
-
Uremic Metabolite Adsorption on Hydroxy-PEO Films
2026-10-03
A 2025 study examines how a defined mixture of uremic metabolites interacts with hydroxy-terminated polyethylene oxide films, showing that adsorption depends on metabolite structure, PEO chain density, exposure duration, and terminal chemistry. The findings challenge the assumption that a low-fouling surface behaves consistently across healthy and disease-associated blood chemistries.
-
6-Thioguanine and DNMT1 Pathways in MCF-7 Cells
2026-10-02
This study shows that 6-thioguanine suppresses MCF-7 breast cancer cell growth through a DNMT1-associated program involving FAS-mediated apoptosis and CDKN1A-dependent G2/M arrest. Its main contribution is the integration of RNA sequencing with phenotypic and protein-level validation, providing a mechanistic framework for studying thiopurine repurposing in breast cancer models.
-
Pseudo-UTP: A Decision Framework for mRNA IVT
2026-10-01
Pseudo-UTP enables controlled mRNA synthesis with pseudouridine modification, but its value depends on how nucleotide chemistry, sequence design, purification, and delivery are evaluated together. This evidence-led guide translates a landmark vaccine study into practical assay and workflow decisions.
-
ICI 118,551 Hydrochloride in Neuroimmune Assays
2026-10-01
ICI 118,551 hydrochloride is a beta2-adrenergic receptor antagonist for dissecting receptor-dependent signaling in complex neuroimmune experiments. This article explains how to use it as a mechanistic control alongside the CKLF1/CCR5 findings reported in ischemic-stroke research.
-
c-Myc Tag Peptide A6003: Assay Mechanism
2026-09-30
The c-Myc Peptide A6003 is a synthetic C-terminal c-Myc epitope used for antibody-competition experiments. It enables controlled displacement of c-Myc-tagged fusion proteins and supports anti-c-Myc antibody binding inhibition without being presented as a cellular c-Myc inhibitor.
-
Rotigotine hydrochloride in Parkinson’s Research
2026-09-30
Rotigotine hydrochloride supports integrated cell, behavioral, and rodent Parkinson’s disease workflows rather than a single endpoint. Its dopamine D2/D3 receptor activity, broader dopaminergic profile, and reported antidepressant-like effects make it useful for connecting motor, oxidative-stress, inflammatory, and mood-related readouts.
-
T-5224 Workflow for AP-1 Inflammation Studies
2026-09-29
T-5224 provides a selective way to connect c-Fos/c-Jun AP-1 activity with cytokines, matrix metalloproteinases, NFAT, and osteoclastogenic responses. This practical workflow also shows how the compound can be used to test whether AP-1 participates in the calcium-linked CGRP/SP-Piezo2 neuroinflammatory axis described in trigeminal neuralgia research.
-
L-Glutathione Reduced in GOT1 Redox Assays
2026-09-29
L-Glutathione Reduced offers a mechanistically informed way to interpret redox changes in GOT1 and pancreatic cancer studies. This guide connects glutathione chemistry with assay design, controls, GST workflows, and the metabolic findings of a key PDAC study.
-
Ro 3306 and the Timing of Mitotic Entry
2026-09-28
Ro 3306 provides a way to hold proliferating cells at the G2-to-mitosis boundary and ask how phase-specific biology shapes the result. Here, we connect CDK1 inhibition with recent evidence that mTORC1 activity oscillates across the cell cycle, then outline a practical, cautious framework for synchronization, DNA repair studies, and translational interpretation.
-
Acetaminophen Research: Drug Effects vs Gene Therapy
2026-09-27
Acetaminophen (paracetamol) is useful for studying analgesic pharmacology, oxidative stress, and cell death—but it is not a model of gene silencing. This article connects practical compound controls with the distinct target-engagement logic of transthyretin amyloid cardiomyopathy research.
-
DiscoveryProbe Natural Product Library Plus for HTS
2026-09-26
DiscoveryProbe Natural Product Library Plus (Catalog No. L1039P) is a natural product library of 1,655 pre-dissolved compounds for high-throughput and high-content screening. It can support exploratory target and cell-based screens, but published CpAdhE results do not establish that this catalog contains the compounds identified in that study.